Clinical Trials Browser

Phase 1/2 × Neoplasm Metastasis × navitoclax × Clear all

NCT02079740 2025-09-30

Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

96 enrolled 30 charts

Neoplasm Metastasis

NCT03366103 2023-10-17

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Phase 1/2 Terminated

15 enrolled 14 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma